Go to your personalised cancer information and support area
Learn more about the dashboardExisting My Macmillan user? Access your events and volunteer services.
The web Directory of Information Materials for People Affected by Cancer is regularly updated and currently has details of over 1,900 booklets, leaflets, books and audiovisual materials for people affected by cancer. Most have been published in the last five years but we have included some older ones that are still useful.
Myeloma UK
Elotuzumab is a new drug that is being investigated for the treatment of myeloma. This factsheet describes briefly what it is, how it works, how it is given, the possible benefits over existing drugs, the possible side-effects, its availability in the UK, and the future.
Myeloma UK
Selinexor is the first in a new family of drugs known as Selective Inhibitor of Nuclear Export (SINE™) compounds. This factsheet explains what it is, how it works, and how it is given. It also describes the evidence (clinical trials) to date, the possible side-effects, and the availability of Selinexor in the UK.
Lymphoma Action
Lymphoma treatment may cause nausea and vomiting (sickness). This factsheet has practical advice to help manage and cope with these side effects, including: sickness as a side effect of chemotherapy, radiotherapy, and biological therapy; acute, anticipatory and delayed sickness; managing sickness; tips to help with eating and drinking; other practical suggestions.
Macmillan Cancer Support
Palbociclib (Ibrance®) is a targeted therapy drug used to treat breast cancer that is oestrogen receptor positive and HER 2 negative. This factsheet describes what it is, how it is given, and possible side effects.
Bowel Cancer UK
This booklet is for people who have been diagnosed with bowel cancer under the age of 50. It gives an introduction to how bowel cancer can affect your body, your emotions, your relationships and your everyday life. It includes the personal experiences of people who have been diagnosed with bowel cancer at a younger age. There are links to more detailed information, contact details for organisations, and a glossary of the medical words used.
Lymphoma Action
This factshhet has information about biosimilars of biological medicines for lymphoma. It covers the following: What is a biosimilar?; How are biosimilars tested and approved?; Why are biosimilars developed?; Rituximab biosimilars; FAQs.
Kidney Cancer UK
This booklet has information about kidney cancer, including the symptoms, diagnosis, staging and grading, and the treatment options. It also briefly discusses life with kidney cancer, including feelings, day-to-day living, money, and support. Includes sources of further information and a glossary.
Macmillan Cancer Support
Trastuzumab (Herceptin®) may be used to treat breast cancer and stomach cancer. It may also be used to treat other cancers as part of a research trial. This factsheet explains how it works, how it is given, and possible side-effects.
Macmillan Cancer Support
Denosumab is a targeted therapy used to treat secondary bone cancer. It is also given to people with certain cancers (breast cancer, prostate cancer) to strengthen their bones. This factsheet describes what denosumab is, how it works, how it is given, and the possible side effects.
Macmillan Cancer Support
This booklet has detailed information about chronic myeloid leukaemia, its symptoms, diagnosis, and treatments. It also covers issues such as fertility and feelings, and includes details of useful organisations, and websites.
Safe payments by:
We're here to provide physical, financial and emotional support. So whatever cancer throws your way, we're right there with you. Contact us
© Macmillan Cancer Support 2019 © Macmillan Cancer Support, registered charity in England and Wales (261017), Scotland (SC039907) and the Isle of Man (604). Also operating in Northern Ireland. A company limited by guarantee, registered in England and Wales company number 2400969. Isle of Man company number 4694F. Registered office: 89 Albert Embankment, London SE1 7UQ. VAT no: 668265007